Fatty Liver on Ultrasound but Normal Blood Tests: What Does It Mean?

Fatty liver on ultrasound with normal blood tests usually means fat has built up in the liver, but the enzyme tests have not picked up signs of liver cell injury. Normal enzymes do not rule out fatty liver disease or scarring. The useful next step is often a check of scarring (fibrosis) risk, rather than more ultrasound scans.

This guide is for adults whose ultrasound report mentions fatty liver, hepatic steatosis or a 'bright' liver, while their liver blood tests came back in range. It explains the tests and what to ask. It cannot tell you how healthy your liver is or which test you need. If your ALT was raised but your ultrasound was normal, see our separate guide on raised ALT with a normal liver ultrasound.

Fatty liver often causes no symptoms. Some symptoms need prompt medical attention whatever your earlier results showed. The NHS advises asking for an urgent appointment or using an urgent advice line if your skin or the whites of your eyes turn yellow. This is jaundice, and it can occur with itchy skin, dark urine or pale stools.

Healthdirect lists other signs of more serious liver disease that need a doctor's review. If you are vomiting blood or feel severely unwell, call your local emergency number.

• Yellow skin or eyes, dark urine or pale stools
• A swollen tummy
• Vomiting blood or black, tarry stools
• Bruising easily or ongoing itchy skin

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the newer name for non-alcoholic fatty liver disease (NAFLD). Both terms describe fat build-up in the liver that is linked to metabolic health rather than heavy alcohol use. Older reports and websites may still use NAFLD.

The NHS describes four stages: fat build-up alone, then inflammation (now called MASH), then scarring (fibrosis), and finally cirrhosis. Most people only have the first stage, which does not usually cause problems. A small number progress to later stages.

The NHS lists factors linked with a higher risk. These include excess weight, especially around the waist, type 2 diabetes, high blood pressure, high cholesterol, polycystic ovary syndrome, low physical activity and being over 50. A clinician will also ask about alcohol, because alcohol can cause fatty liver too.

Liver enzymes such as ALT and AST can leak into the blood when liver cells are injured. Fat can sit in the liver without causing enough injury to push these enzymes outside the laboratory range. MedlinePlus notes that the amount of ALT in the blood is not related to how much the liver may be damaged.

The American Association for the Study of Liver Diseases (AASLD) guidance notes that AST can be normal in people with diabetes, MASH and advanced fibrosis. It also says many laboratories set their normal range for ALT higher than what should be considered normal in fatty liver disease. So a result marked normal does not settle the question. Reference ranges also differ between laboratories.

On ultrasound, a fatty liver looks brighter than a normal liver, according to RadiologyInfo. That is how fatty liver is often found by chance on a scan done for another reason.

NIDDK explains that routine imaging can show fat but cannot show inflammation or fibrosis. AASLD guidance adds that ordinary ultrasound can miss milder fat build-up, particularly in people with obesity. Its estimate of how much fat is present is subjective. A report that only mentions fat says little about scarring, and scarring matters most for long-term liver health.

AASLD guidance recommends that people found to have fatty liver on imaging, with no other cause, have a risk assessment for advanced fibrosis. This usually starts with a FIB-4 score. FIB-4 is calculated from age and routine blood results, and NIDDK notes such scores can help identify or rule out advanced scarring. In the guidance, a FIB-4 below 1.3 suggests low risk. The guidance notes the score is less accurate under age 35 and uses a different cut-off over 65.

If FIB-4 is not low, the guidance suggests a second test. This is often vibration-controlled transient elastography, an ultrasound-based scan that measures liver stiffness, or an ELF blood test. Other options include shear wave elastography and magnetic resonance elastography. A stiffer liver can be a sign of scarring.

Liver biopsy is not needed for most people. NIDDK says it is the only test that can prove MASH and show clearly how severe it is. Doctors usually consider it when other tests suggest advanced disease or another liver condition needs ruling out.

Next steps depend on your overall risk, not just the ultrasound wording. The NHS recommends a balanced diet, regular physical activity, losing weight if you are overweight, keeping alcohol within recommended limits and not smoking. Lifestyle changes can help stop fatty liver from progressing. A clinician may also review blood sugar, blood pressure and cholesterol, because these often go together with MASLD.

Follow-up varies. AASLD guidance suggests repeating the fibrosis risk check every 1 to 2 years for people with prediabetes, type 2 diabetes or two or more metabolic risk factors. For others, every 2 to 3 years may be enough. A higher score may lead to referral to a liver specialist. Do not start supplements or stop prescribed medicines to change liver results without discussing it first.

Bring your ultrasound report and recent blood results, including the reference ranges and dates.

• Is the fat most likely metabolic, or could alcohol, medicines or another condition be contributing?
• Has my risk of scarring been assessed? Do I have a FIB-4 score, and what was it?
• Do I need a liver stiffness test such as elastography, and what would the result change?
• Which of my other results, such as blood sugar, blood pressure or cholesterol, need attention too?
• When should the fibrosis check be repeated, and who will arrange it?
• Which symptoms should make me seek care sooner?

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar ultrasound finding were followed up can show which questions they asked. For example, some asked whether a FIB-4 score was calculated or how often stiffness was rechecked. We do not diagnose, and another person's path may not match yours. Use what you read to prepare questions for your own clinician.